These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 217260)

  • 1. Thymectomy does not affect tumour rejection and cytophilic activity in a murine allogeneic lymphoma model.
    Barrera CN; Mazzolli AB; Colmerauer ME; Pasqualini CD
    Allergol Immunopathol (Madr); 1978; 6(5):403-8. PubMed ID: 217260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Functional lymphoma capable of restoring the thymic response of an allogeneic mouse].
    Piazzon I; Déroche A; Matusevich M; Pasqualini CD
    Medicina (B Aires); 1979; 39(3):351-6. PubMed ID: 42002
    [No Abstract]   [Full Text] [Related]  

  • 3. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytophilic activity associated with murine allogeneic tumor rejection.
    Mazzolli AB; Barrera CN; Colmerauer ME; Pasqualini CD
    Medicina (B Aires); 1978; 38(6 Pt 1):639-42. PubMed ID: 374929
    [No Abstract]   [Full Text] [Related]  

  • 7. Conditions favoring immunological enhancement of a murine allogeneic lymphoma.
    Rumi L; Colmerauer ME; Pasqualini CD
    Arch Geschwulstforsch; 1976; 46(6):457-60. PubMed ID: 63273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones.
    Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT
    J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
    Müerköster S; Wachowski O; Zerban H; Schirrmacher V; Umansky V; Rocha M
    Clin Cancer Res; 1998 Dec; 4(12):3095-106. PubMed ID: 9865926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus.
    Sharma JM; Herberman RB; Djeu JY; Nunn ME
    J Immunol; 1979 Jul; 123(1):222-31. PubMed ID: 221590
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies against a tumour-associated antigen in an AKR lymphoma conditioned to grow in BALB/c mice.
    Hajos SE; Alvarez E; Pierangeli S; Pasqualini CD; Margni RA
    Vet Immunol Immunopathol; 1984 Aug; 7(1):53-63. PubMed ID: 6485248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Termination of the B cell lymphoma dormant state in thymectomized AKR mice.
    Haran-Ghera N; Peled A; Brightman BK; Fan H
    J Immunol; 1992 May; 148(9):2947-52. PubMed ID: 1349324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
    Prager MD; Granatek CH; Ludden CM
    Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of the graft versus host reaction during allogeneic tumour enhancement.
    Piazzon I; Déroche A; Pasqualini CD
    Arch Geschwulstforsch; 1980; 50(4):322-6. PubMed ID: 7458579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Ly-1+ B-cell populations and IgH rearrangements in "normal" spleens and in lymphomas of AKR/J and AKR Fv-1b mice.
    Rosner A; Peled A; Haran-Ghera N; Canaani E
    Cancer Res; 1993 May; 53(9):2147-53. PubMed ID: 7683252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.